The United States has approved Pfizer and Moderna coronavirus (COVID-19) vaccines for children as young as six months. The US Food and Drug Administration granted emergency authorisation Friday (June 17) for the use of Pfizer and Moderna jabs in the youngest children. This age group is the final age group that is awaiting immunisation against the deadly COVID-19 in most countries.&nbsp;This means almost every person in the US is now eligible for vaccination.&nbsp;

"Many parents, caregivers and clinicians have been waiting for a vaccine for younger children and this action will help protect those down to six months of age," Food and Drug Administration chief Robert Califf said in a statement.&nbsp;

"We expect that the vaccines for younger children will provide protection from the most severe outcomes of Covid-19, such as hospitalisation and death."&nbsp;

The agency authorized Moderna's two-dose vaccine for children aged six months to five years, and three doses of Pfizer's shots for those between six months and four years old.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/world/people-infected-with-omicron-variant-less-likely-to-get-long-covid-19-in-comparison-to-delta-study-489053">People infected with Omicron variant less likely to get long COVID-19 in comparison to Delta: Study</a>&nbsp;

The decision was announced after the FDA's committee of independent vaccine experts voted unanimously to recommend the jabs. In a lengthy meeting on Wednesday, the committee analysed the safety and effectiveness of the vaccines.&nbsp;

However, it must be recommended by the Centers for Disease Control and Prevention (CDC) before they are put into use. Meanwhile, the US government has said that as soon as the FDA decision is made, 10 million doses could immediately be sent around the country, followed by millions more in subsequent weeks.&nbsp;

As mentioned by NBC News, the White House expects vaccinations to begin as soon as Tuesday.&nbsp;

There are some 20 million children aged four years and under in the United States.&nbsp;

(With inputs from agencies)&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The United States has approved Pfizer and Moderna coronavirus (COVID-19) vaccines for children as young as six months. The US Food and Drug Administration granted emergency authorisation Friday (June 17) for the use of Pfizer and Moderna jabs in the youngest children.

The United States has approved Pfizer and Moderna coronavirus (COVID-19) vaccines for children as young as six months. The US Food and Drug Administration granted emergency authorisation Friday (June 17) for the use of Pfizer and Moderna jabs in the youngest children. This age group is the final age group that is awaiting immunisation against the deadly COVID-19 in most countries. This means almost every person in the US is now eligible for vaccination. "Many parents, caregivers and clinicians have been waiting for a vaccine for younger children and this action will help protect those down to six months of age," Food and Drug Administration chief Robert Califf said in a statement. "We expect that the vaccines for younger children will provide protection from the most severe outcomes of Covid-19, such as hospitalisation and death." The agency authorized Moderna's two-dose vaccine for children aged six months to five years, and three doses of Pfizer's shots for those between six months and four years old. ALSO READ | People infected with Omicron variant less likely to get long COVID-19 in comparison to Delta: Study The decision was announced after the FDA's committee of independent vaccine experts voted unanimously to recommend the jabs. In a lengthy meeting on Wednesday, the committee analysed the safety and effectiveness of the vaccines. However, it must be recommended by the Centers for Disease Control and Prevention (CDC) before they are put into use. Meanwhile, the US government has said that as soon as the FDA decision is made, 10 million doses could immediately be sent around the country, followed by millions more in subsequent weeks. As mentioned by NBC News, the White House expects vaccinations to begin as soon as Tuesday. There are some 20 million children aged four years and under in the United States. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

COVID-19: US approves Pfizer and Moderna jabs for kids as young as 6 months

The Food and Drug Administration should provide an emergency use permission for the Pfizer-BioNTech vaccine in children aged 5 to 11 years old, according to a panel of independent advisors.

There were 17 yes votes and one no vote.

Pfizer's evidence suggesting that the vaccine is safe and 90.7 per cent effective in preventing COVID-19 infections in this age range was accepted by the FDA panel.

Though it isn't obligated to, the agency usually follows the advise of its expert panels.

Within the following several days, it will make a choice.&nbsp; 
 
Watch | Gravitas: Why India needs to begin vaccinating Children

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-why-india-needs-to-begin-vaccinating-children-421905/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

If the FDA approves the vaccine for these younger children, which appears likely, a panel of specialists advising the Centers for Disease Control and Prevention will make its own recommendations and issue guidance on its usage among this age range next week.&nbsp;

Despite the majority in favour, the experts looked to be struggling to decide if the advantages of vaccination for young children outweighed the hazards.&nbsp;

Children aged 5 to 11 receive a lower dosage of the vaccination than those aged 12 and up: 10 micrograms of mRNA vs 30 micrograms.

The whole vaccine series, much like in adults, comprises of two doses given three weeks apart.

The dosages for youngsters will be in vials with an orange lid and label.

Adult and teen dosages are packaged in vials with a purple lid and label.&nbsp;

(With inputs from agencies)

The Food and Drug Administration should provide an emergency use permission for the Pfizer-BioNTech vaccine in children aged 5 to 11 years old, according to a panel of independent advisors.

The Food and Drug Administration should provide an emergency use permission for the Pfizer-BioNTech vaccine in children aged 5 to 11 years old, according to a panel of independent advisors. There were 17 yes votes and one no vote. Pfizer's evidence suggesting that the vaccine is safe and 90.7 per cent effective in preventing COVID-19 infections in this age range was accepted by the FDA panel. Though it isn't obligated to, the agency usually follows the advise of its expert panels. Within the following several days, it will make a choice. Watch | Gravitas: Why India needs to begin vaccinating Children If the FDA approves the vaccine for these younger children, which appears likely, a panel of specialists advising the Centers for Disease Control and Prevention will make its own recommendations and issue guidance on its usage among this age range next week. Despite the majority in favour, the experts looked to be struggling to decide if the advantages of vaccination for young children outweighed the hazards. Children aged 5 to 11 receive a lower dosage of the vaccination than those aged 12 and up: 10 micrograms of mRNA vs 30 micrograms. The whole vaccine series, much like in adults, comprises of two doses given three weeks apart. The dosages for youngsters will be in vials with an orange lid and label. Adult and teen dosages are packaged in vials with a purple lid and label. (With inputs from agencies)

COVID-19 vaccine for kids: FDA panel OKs Pfizer vaccine for children aged 5 to 11

covid-19-vaccine-for-kids

Covid 19 Vaccine For Kids, News on Covid 19 Vaccine For Kids, stories on Covid 19 Vaccine For Kids, articles on Covid 19 Vaccine For Kids, Covid 19 Vaccine For Kids stories at Wion, Covid 19 Vaccine For Kids news, Covid 19 Vaccine For Kids latest news

covid 19-vaccine-for-kids

COVID-19: US approves Pfizer and Moderna jabs for kids as young as 6 months

COVID-19 vaccine for kids: FDA panel OKs Pfizer vaccine for children aged 5 to 11